[CYCC] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -450.17%
YoY- -164.76%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 205 715 735 309 38 164 159 4.32%
PBT -3,400 -3,187 -5,661 -5,746 -3,572 -3,571 -3,950 -2.46%
Tax -454 -478 -750 -730 -419 -126 -143 21.21%
NP -2,946 -2,709 -4,907 -5,004 -1,890 -3,445 -3,807 -4.17%
Tax Rate - - - - - - - -
Total Cost 3,151 3,424 5,642 5,313 1,928 3,609 3,966 -3.75%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -1,437.07 -378.88 -667.62 -1,619.42 -4,973.68 -2,100.61 -2,394.34 -8.14%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -16.96 -18.75 -51.93 -67.51 -53.81 -107.75 -172.72 -32.05%
EPS Diluted -16.96 -18.75 -51.93 -67.51 -53.81 -107.75 -172.72 -32.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.